Image-guided therapy developer ViewRay of Oakwood Village, OH, has secured $20 million in financing from a new investor, Siemens Venture Capital, and existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, and OrbiMed Advisors.
The funding will support the commercialization and installation of the ViewRay image-guided radiation therapy system, which is now in the late stages of development.
The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of simultaneous MRI and radiation therapy delivery. The technology currently is designated for nonclinical research use only.
The Siteman Cancer Center at Barnes-Jewish Hospital and the Washington University School of Medicine in St. Louis are expected to validate the ViewRay system.
Related Reading
SPIE: Is MRI-guidance the next step for IGRT? May 21, 2010
ViewRay partners with Siemens, closes financing, April 14, 2009
Copyright © 2010 AuntMinnie.com
_p888_f1_thumb.png?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
